FDA approves GLP-1 generic for Type 2 diabetes

By The Hill | Created at 2024-12-24 20:01:24 | Updated at 2024-12-25 09:19:42 13 hours ago

The U.S. Food and Drug Administration (FDA) has approved a generic daily injectable for the GLP-1 medication for patients who are 10 years old and up with Type 2 diabetes. The liraglutide injection, which is currently in shortage and sold under the brand name Victoza, will provide a low-cost option for those who need GLP-1…

Read Entire Article